Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuro Diagnostic Devices (NeuroDx) is a medical technology company dedicated to improving the lives of patients with hydrocephalus through advanced diagnostic solutions. The company's flagship product, ShuntCheck, is a non-invasive, FDA-cleared device that utilizes proprietary thermal dilution technology to detect cerebrospinal fluid (CSF) flow in implanted shunts. By providing rapid, bedside confirmation of shunt flow, the technology assists neurosurgeons and emergency department physicians in ruling out shunt obstructions, thereby reducing the need for expensive imaging and invasive diagnostic procedures. Headquartered in Pennsylvania, Neuro Diagnostic Devices collaborates with leading pediatric hospitals to integrate its "confirmatory rule-out" test into standard clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro Diagnostic Devices.